These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa. Malini PL; Strocchi E; Ambrosioni E; Magnani B Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071 [TBL] [Abstract][Full Text] [Related]
4. [Therapy of hypertension with Leron (cyclacenin) and Tadip (cyclacenin and alpha-methyldopa)]. Stampfer E Wien Med Wochenschr; 1968 Jun; 118(24):551-4. PubMed ID: 5711781 [No Abstract] [Full Text] [Related]
5. The position of beta-blockers in antihypertensive therapy. Comparison with other antihypertensive agents. Brunner HR; Waeber B; Ferguson RK; Turini GA; Gavras H Cardiology; 1979; 64 Suppl 1():88-95. PubMed ID: 42489 [No Abstract] [Full Text] [Related]
7. [The broad-spectrum antihypertensive agent Tadip in slight and moderate hypertension]. Kempf E Med Monatsschr; 1968 Jun; 22(6):270-5. PubMed ID: 5720912 [No Abstract] [Full Text] [Related]
8. [Therapeutic trials with the new antihypertensive agent Tadip]. Stein G Med Klin; 1968 Sep; 63(37):1466-8. PubMed ID: 5730203 [No Abstract] [Full Text] [Related]
9. A comparative study of a new alpha-adrenoceptor agonist, guanfacine and alpha-methyldopa in the treatment of hypertension. Joshi RC; De A; Cameron EG Br J Clin Pract; 1984 Feb; 38(2):66-7, 71. PubMed ID: 6142723 [No Abstract] [Full Text] [Related]
10. [A controlled blind study of 4 antihypertensive agents (methyldopa and 3 sympatholytic agents)]. Vejlsgaard V; Christensen M; Clausen E Ugeskr Laeger; 1967 May; 129(19):635-8. PubMed ID: 4877293 [No Abstract] [Full Text] [Related]
12. Clinical evaluation of Declinax in Nigerian hypertensives. Cole TO; Adadevoh BK Br J Clin Pract; 1970 Jun; 24(6):245-9. PubMed ID: 5456743 [No Abstract] [Full Text] [Related]
13. A comparison of guanoclor and methyldopa in the treatment of severe hypertension. Mackinnon J; el-Baz LM Br J Clin Pract; 1971 Mar; 25(3):135-7. PubMed ID: 4929159 [No Abstract] [Full Text] [Related]
14. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study. Viskoper RJ; Laszt A; Paran E; Ben Ari J; Goren Y; Modan M Neth J Med; 1987 Aug; 31(1-2):58-65. PubMed ID: 3309693 [No Abstract] [Full Text] [Related]
15. The decline in stroke mortality: the limited role of antihypertensive therapy. Bonita R; Beaglehole R N Z Med J; 1987 Jul; 100(828):454-6. PubMed ID: 3330190 [No Abstract] [Full Text] [Related]
16. [Effect of antihypertensive drug treatment on the incidence of cardiovascular morbidity and mortality in mild arterial hypertension]. Tomov I Vutr Boles; 1985; 24(6):39-47. PubMed ID: 3913145 [No Abstract] [Full Text] [Related]
17. Letter: Debrisoquine, guanethidine, and bethanidine in hypertension. Talbot S; O'Malley BC; Bing RH Br Med J; 1975 May; 2(5965):278. PubMed ID: 1131592 [No Abstract] [Full Text] [Related]
18. [Blood pressure regulation in stroke. Current aspects. 105th Congress of the German Society for Internal Medicine, Wiesbaden 12 April 1999]. Dtsch Med Wochenschr; 1999 Jul; 124(27 Suppl):1-4. PubMed ID: 10439831 [No Abstract] [Full Text] [Related]